CASE COMMENT: UNILATERAL PRACTICES - INTELLECTUAL PROPERTY

Intellectual property rights: The European Commission rules on how to fit intellectual property rights and competition rules (Astra Zeneca)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. EC Commission, Press release IP/05/737 of 15 June 2005, AstraZeneca, Case COMP/37.507 The European Commission's decision in the AstraZeneca case is original to say the least; it is representative of the Commission's determination to combat all types of abuse of a dominant position, even those involving intellectual property rights. In this case, the European Commission alleges that between 1993 and 2000, AstraZeneca misused the patent system

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Anne Wachsmann, Intellectual property rights: The European Commission rules on how to fit intellectual property rights and competition rules (Astra Zeneca), 15 June 2005, Concurrences N° 3-2005, Art. N° 1176, pp. 77-78

Visites 4360

All reviews